Royalty Pharma Plc (RPRX) — Capital Reinvestment Ratio
Royalty Pharma Plc (RPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($702.62 Million) in capital expenditures ($1.11 Million). Check Royalty Pharma Plc (RPRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Royalty Pharma Plc Capital Reinvestment Ratio (2002–2023)
This chart tracks Royalty Pharma Plc's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see RPRX cash flow metrics.
Annual Capital Reinvestment Ratio for Royalty Pharma Plc (2002–2023)
Year-by-year Capital Reinvestment Ratio for Royalty Pharma Plc from 2002 to 2023. See how much free cash does Royalty Pharma Plc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.71x | $2.99 Billion | $2.12 Billion | ▼ -25.6% |
| 2022 | 0.95x | $2.14 Billion | $2.04 Billion | ▲ +367160.5% |
| 2021 | 0.00x | $2.02 Billion | $523.00K | ▼ -100.0% |
| 2020 | 1.08x | $2.03 Billion | $2.20 Billion | ▲ +4.6% |
| 2019 | 1.03x | $1.67 Billion | $1.72 Billion | ▲ +519.7% |
| 2018 | 0.17x | $1.62 Billion | $269.59 Million | ▼ -89.7% |
| 2017 | 1.62x | $1.42 Billion | $2.29 Billion | ▲ +27735.6% |
| 2002 | 0.01x | $8.45 Million | $49.00K | — |